OrbiMed

OrbiMed

U.S-based venture capital and private equity firm investing on life sciences companies worldwide.

All edits

Edits on 13 November, 2019
Carla Faraguna
Carla Faraguna edited on 13 November, 2019 10:00 pm
Edits made to:
Infobox (+2 properties)

Infobox

Carla Faraguna
Carla Faraguna edited on 13 November, 2019 10:00 pm
Edits made to:
Infobox (+4 properties)
Edits on 22 October, 2019
Henry Ogolla"Approved suggestion #670155"
Henry Ogolla approved a suggestion from Golden's AI on 22 October, 2019 5:59 pm
Edits made to:
Infobox (+1 properties)
Edits on 7 October, 2019
Neelam Jhaveri
Neelam Jhaveri edited on 7 October, 2019 5:46 am
Edits made to:
Infobox (+1 properties)
Edits on 23 August, 2019
Neelam Jhaveri
Neelam Jhaveri edited on 23 August, 2019 7:06 am
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 13 August, 2019
Neelam Jhaveri
Neelam Jhaveri edited on 13 August, 2019 8:19 am
Edits made to:
Infobox (+1 properties)
Article

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

...

OrbiMed focuses on funding companies in the field of life sciences. The firm invests globally, with past investments on companies based in North America, Europe, and Asia (China, India, and Israel). The firm finances companies at various stages of development, from seed to buyouts. Its most recent funding round raised $551 million on September 2017.

Infobox

Edits on 25 April, 2019
Golden AI
Golden AI edited on 25 April, 2019 12:53 am
Edits made to:
Infobox (+1 properties)

Infobox

Industry
Edits on 15 April, 2019
Golden AI
Golden AI edited on 15 April, 2019 9:08 am
Edits made to:
Infobox (-1 properties)
Edits on 4 April, 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 4 April, 2019 9:32 pm
Edits made to:
Article (+20/-20 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firmventure capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Edits on 3 April, 2019
Golden AI
Golden AI edited on 3 April, 2019 11:49 am
Edits made to:
Infobox (+1 properties)
Edits on 22 March, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 22 March, 2019 4:52 pm
Edits made to:
Article (+5/-5 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for ImaraImara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Edits on 21 March, 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 21 March, 2019 12:21 am
Edits made to:
Article (+6/-6 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; Herzliya, IsraelIsrael and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Edits on 19 March, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 19 March, 2019 10:46 pm
Edits made to:
Article (+6/-6 characters)

Article

OrbiMed focuses on funding companies in the field of life sciences. The firm invests globally, with past investments on companies based in North America, EuropeEurope, and Asia (China, India, and Israel). The firm finances companies at various stages of development, from seed to buyouts. Its most recent funding round raised $551 million on September 2017.

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 19 March, 2019 10:45 pm
Edits made to:
Article (+5/-5 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, IndiaIndia; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 19 March, 2019 6:24 pm
Edits made to:
Article (+10/-10 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, CaliforniaCalifornia; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 19 March, 2019 6:15 pm
Edits made to:
Article (+5/-5 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, ChinaChina; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 19 March, 2019 2:03 pm
Edits made to:
Article (+8/-8 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; ShanghaiShanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 19 March, 2019 2:03 pm
Edits made to:
Article (+13/-13 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San FranciscoSan Francisco, California; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 19 March, 2019 2:03 pm
Edits made to:
Article (+13/-13 characters)

Article

OrbiMed focuses on funding companies in the field of life sciences. The firm invests globally, with past investments on companies based in North AmericaNorth America, Europe, and Asia (China, India, and Israel). The firm finances companies at various stages of development, from seed to buyouts. Its most recent funding round raised $551 million on September 2017.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 19 March, 2019 2:03 pm
Edits made to:
Article (+4/-4 characters)

Article

OrbiMed focuses on funding companies in the field of life sciences. The firm invests globally, with past investments on companies based in North America, Europe, and AsiaAsia (China, India, and Israel). The firm finances companies at various stages of development, from seed to buyouts. Its most recent funding round raised $551 million on September 2017.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.